Catalyst Wire Dossier Catalyst Wire Dossier

K-321 Eye Drops

K-321 · Kowa Research Institute, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for K-321 Eye Drops, covering 2026-01-22 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) [Phase 3]

See pricing